Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers (original) (raw)
Chemotherapy in glioma
Martin Van Den Bent
CNS oncology, 2015
View PDFchevron_right
Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma
Giuseppe Minniti
Tumori, 2010
View PDFchevron_right
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Ulrike Ernemann
Journal of Clinical Oncology, 2009
View PDFchevron_right
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
Santosh Kesari
Neuro-Oncology, 2007
View PDFchevron_right
Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
Uma Shankavaram
PLoS ONE, 2013
View PDFchevron_right
Tumor Treating Fields and New Paradigms in Glioblastoma Standard of Care
Roger Rotta
2020
View PDFchevron_right
Impact of radiotherapy delay on survival in glioblastoma
Teresa Ribalta, Estela Pineda
Clinical and Translational Oncology, 2013
View PDFchevron_right
Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors
Giovanni Melillo
Journal of Neuro-Oncology, 1985
View PDFchevron_right
Is re-radiation for glioblastoma after progression associated with increased survival: to treat or not to treat?
Santosh Kesari
Translational Cancer Research, 2019
View PDFchevron_right
Early chemotherapy and concurrent radio-chemotherapy in high grade glioma
Franco Berti, Marina Gardiman
Journal of Neuro-Oncology, 1996
View PDFchevron_right
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
Martin Van Den Bent
Journal of Neuro-Oncology, 2012
View PDFchevron_right
Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide
Gianfranco Pesce, Michael Brada
Annals of Oncology, 2005
View PDFchevron_right
Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?
Nadia Laack
Seminars in Radiation Oncology, 2015
View PDFchevron_right
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Kathryn Carson
Clinical Cancer Research, 2010
View PDFchevron_right
Changing Paradigms--An Update on the Multidisciplinary Management of Malignant Glioma
Martin Van Den Bent
The Oncologist, 2006
View PDFchevron_right
High grade gliomas. Multidisciplinar treatment with radiotherapy and concurrent carmustine after surgery
Gaspar Reynes
Clinical and Translational Oncology, 2004
View PDFchevron_right
Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis
Emel Yaman
Tumori
View PDFchevron_right
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study
Alba Fiorentino
Journal of Neuro-Oncology, 2010
View PDFchevron_right
Survival of High Grade Glioma Patients Treated by Three Radiation Schedules with Chemotherapy: A Retrospective Comparative Study
Hamza Abubakar
Research in Oncology, 2017
View PDFchevron_right
High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy
Vincenzo Tombolini
Anticancer research
View PDFchevron_right
Survival improvements with adjuvant therapy in patients with glioblastoma
Dasantha Jayamanne
ANZ Journal of Surgery, 2017
View PDFchevron_right
Recent updates in the treatment of glioblastoma: introduction
Steven Brem
Seminars in oncology, 2014
View PDFchevron_right
Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols
Dr. Arun S. Oinam
Neuro-Oncology Practice, 2019
View PDFchevron_right
Randomized Study of Postoperative Radiotherapy and Simultaneous Temozolomide without Adjuvant Chemotherapy for Glioblastoma
Gerd Becker
Strahlentherapie und Onkologie, 2008
View PDFchevron_right
Adjuvant treatment of Grade 4 Glioma, outcomes at a UK tertiary centre
Louise Price
View PDFchevron_right
Influence of Oncotherapy and Clinical Parameters on Survival of Glioblastoma Patients: A Single Center Experience
László Bognár
Neurology India, 2019
View PDFchevron_right
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma
Nicholas Butowski, Dario J Englot, Harjus Birk
Neurosurgery, 2015
View PDFchevron_right
Short Course versus Standard Course of Radiotherapy in Glioblastoma Multiforme
Amr Sakr
Journal of Nuclear Medicine & Radiation Therapy, 2018
View PDFchevron_right
New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach
Hugues Duffau
Neuro-oncology, 2014
View PDFchevron_right
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Martin Van Den Bent
Neuro-oncology, 2017
View PDFchevron_right
A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey
Christoph Straube
BMC Cancer, 2018
View PDFchevron_right
A clinical review of treatment outcomes in glioblastoma multiforme--thevalidation in a non-trial population of the results of a randomised PhaseIII clinical trial: has a more radical approach improved survival?
Mary Dunne
British Journal of Radiology, 2012
View PDFchevron_right
Response and progression in recurrent malignant glioma
Athanassios Kyritsis
Neuro-Oncology, 1999
View PDFchevron_right